SEC Form 4 · accession 0001170362-15-000001
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven W Spector
Officer — EVP, General Counsel & Sec
Period of report
Jan 8, 2015
Accepted (ET)
Jan 8, 2015 · 9:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2015 | M | 45,000 | $6.16 | A | 173,039 | D | |
| Common Stock | Jan 8, 2015 | S | 45,000 | $6.26 | D | 128,039 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $6.16 | Jan 8, 2015 | M | 45,000 | D | — | Jan 17, 2015 | Common Stock | 45,000 | 0 | D |
Explanation of responses
- F1The amount includes shares purchased under Arena's employee stock purchase plan prior to the reported transaction.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- F3The options were exercisable upon grant, and vested in four equal annual installments beginning on January 17, 2006.